Principal Financial Group
CALA

Principal Financial Group’s Calithera Biosciences, Inc CALA Stock Holding History

Principal Financial Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-761
Closed -$37K – 2676
2021
Q1 		$37K Sell
761
-119
-14% -$6.93K ﹤0.01% 2468
2020
Q4 		$86K Buy
880
+366
+71% +$32.1K ﹤0.01% 2365
2020
Q3 		$35K Sell
514
-29
-5% -$2.53K ﹤0.01% 2307
2020
Q2 		$57K Buy
+543
New +$64.5K ﹤0.01% 2280
2018
Q2 		– Sell
-967
Closed -$122K – 2321
2018
Q1 		$122K Buy
967
+81
+9% +$12.6K ﹤0.01% 2145
2017
Q4 		$148K Buy
+886
New +$227K ﹤0.01% 2162

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group's CALA Position: Q2 2021 in Review

Principal Financial Group sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 761 shares — an estimated $37K sold.

Principal Financial Group first reported a position in CALA in Q4 2017 and held it in 6 quarters. The position peaked at $148K in Q4 2017. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Principal Financial Group reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Principal Financial Group sold 761 Calithera Biosciences, Inc shares in Q2 2021, an estimated $37K.
  • Principal Financial Group first reported a position in Calithera Biosciences, Inc in Q4 2017 and held it in 6 quarters.
  • Principal Financial Group's Calithera Biosciences, Inc position peaked at $148K in Q4 2017.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Principal Financial Group's 13F filing for Q2 2021, filed 10 Aug 2021.